26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer

Journal of Cellular Biochemistry

Volumn 82, Issue 1, 2001, Pages 110-122

  Yang, Xionghu ^a   Taylor, Linda ^a   Polgar, Peter ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell cycle; Mouse xenografts; NF B; P21; PS 341

Indexed keywords

BORONIC ACID DERIVATIVE; BORTEZOMIB; CYCLIN DEPENDENT KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRINOTECAN; PROTEASOME; PROTEIN P21; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL DIVISION; CONTROLLED STUDY; HUMAN; HUMAN CELL; METASTASIS; MITOSIS INHIBITION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN DEGRADATION; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BORONIC ACIDS; CAMPTOTHECIN; CELL CYCLE; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DIPEPTIDES; DRUG RESISTANCE, NEOPLASM; HUMANS; MICE; MICE, NUDE; MITOGENS; NF-KAPPA B; PANCREATIC NEOPLASMS; PEPTIDE HYDROLASES; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PYRAZINES; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0034981649     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.1150     Document Type: Article

References (44)

1. Novel inhibitors of the proteasome and their therapeutic use in inflammation
2. Proteasome inhibitors: A novel class of potent and effective antitumor agents
3. CDKN2 and K-ras mutations as diagnostic and prognostic markers for ductal adenocarcinoma of the pancreas
4. An essential role for NF-κB in preventing TNF-α-induced cell death
5. A Phase III study of gemcitabine and 5-fluorouracil in metastatic pancreatic cancer: An Eastern Cooperative Oncology Group Study (E3296)
6. Modulation of drug cytotoxity by reintroduction of wild type p53 gene (AdCMV-p53) in human pancreatic cancer
7. Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycampothecin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-κB activation
8. Apoptosis in cancer therapy: Crossing the threshold
9. Cyclin is degraded by the ubiquitin pathway
10. Cancer Statistics 2000
11. Apoptosis and the proteasome
12. Proteasomes play an essential role in thymocyte apoptosis
13. Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcriptional factor NF-κB
14. Degradation of tyrosine aminotransferase (TAT) via the ubiquitin-proteasome pathway
15. Proteasome inhibition enhances the stability of mouse Cu/Zn superoxide dismutase with mutations linked to familial amyotrophic lateral sclerosis
16. NF-κB activation by campothecin
17. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis in human monoblast U937 cells
18. Immunotherapy of cancer
19. How proteolysis drives the cell cycle
20. Sodium salicylate activates caspases and induces apoptosis of myeloid leukemia cell lines
21. Experimental drugs and drug combinations in pancreatic cancer
22. Proteasome inhibitors: Valuable new tools for cell biologists
23. p53-dependent induction of apoptosis by proteasome inhibitors
24. Loss of p27Kip1 expression independently predicts poor prognosis for patients with resectable pancreatic adenocarcinoma
25. Ubiquitin-proteasome inhibition enhances apoptosis of human pancreatic cancer cells
26. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
27. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB
28. The molecular and cellular biology of pancreatic cancer
29. Sodium salicylate inhibits proliferation and induces G1 cell cycle arrest in human pancreatic cancer cell lines
30. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules
31. Effects on NF-κB1/p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome
32. Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons
33. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
34. A sensitive and rapid gel retention assay for nuclear factor I and other DNA-binding proteins in crude nuclear extracts
35. Multiple nuclear factors interact with the immunoglobulin enhancer sequences
36. Pancreatic cancer: A report of treatment and survival trends for 1,00,313 patients diagnosed from 1985-1995, using the National Cancer Database
37. Cancer cell cycles
38. The proteasome inhibitor PS-341 in cancer therapy
39. Suppression of TNF-α-induced apoptosis by NF-κB
40. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
41. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
42. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB
43. Current status of and future prospects for the medical management of adenocarcinoma of the exocrine pancreas